Search Thermo Fisher Scientific
MA5-17105 targets KCNQ1 in indirect ELISA, FACS and WB applications and shows reactivity with Human samples.
The MA5-17105 immunogen is purified recombinant fragment of human KCNQ1 expressed in E. Coli.
MA5-17105 detects KCNQ1 which has a predicted molecular weight of approximately 95kDa.
Voltage-gated K+ channels in the plasma membrane control the repolarization and the frequency of action potentials in neurons, muscles and other excitable cells. A specific K+ channel, comprised of an alpha subunit KCNQ1 and a beta subunit KCNE1, a small protein which spans the membrane only once, is predominantly expressed in the heart and in the cochlea, and is responsible for regulating the slow, depolarization-activated potassium current. Mutations in the genes encoding for KCNQ1 and KCNE1 lead to cardiac disease because they directly impair electrical signaling, and mutations in KCNQ4 are implicated in the onset of deafness. KCNQ proteins, including KCNQ1 and KCNQ4, characteristically contain six transmembrane domains and function as tetramers. KCNQ4 forms heteromeric channels with KCNQ3 and is expressed in several tissues, including the cochlea, where it is present in outer hair cells.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: FLJ26167; IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1; kidney and cardiac voltage dependend K+ channel; KQT-like 1; potassium channel, voltage gated KQT-like subfamily Q, member 1; Potassium voltage-gated channel subfamily KQT member 1; potassium voltage-gated channel, KQT-like subfamily, member 1; slow delayed rectifier channel subunit; Voltage-gated potassium channel subunit Kv7.1
基因别名: ATFB1; ATFB3; JLNS1; KCNA8; KCNA9; KCNQ1; Kv1.9; Kv7.1; KVLQT1; LQT; LQT1; RWS; SQT2; WRS
UniProt ID: (Human) P51787
Entrez Gene ID: (Human) 3784